DexCom, Inc. (LON:0A4M)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of GBP 19.26 billion. The enterprise value is 18.71 billion.

Market Cap	19.26B
Enterprise Value	18.71B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	390.02M
Shares Outstanding	n/a
Shares Change (YoY)	-1.89%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	97.19%
Float	387.42M

Valuation Ratios

The trailing PE ratio is 35.93 and the forward PE ratio is 27.17.

PE Ratio	35.93
Forward PE	27.17
PS Ratio	5.73
PB Ratio	9.50
P/TBV Ratio	9.87
P/FCF Ratio	24.39
P/OCF Ratio	17.88
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.64, with an EV/FCF ratio of 23.68.

EV / Earnings	34.89
EV / Sales	5.54
EV / EBITDA	23.64
EV / EBIT	32.17
EV / FCF	23.68

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.94.

Current Ratio	1.56
Quick Ratio	1.35
Debt / Equity	0.94
Debt / EBITDA	2.43
Debt / FCF	2.43
Interest Coverage	40.93

Financial Efficiency

Return on equity (ROE) is 30.63% and return on invested capital (ROIC) is 9.85%.

Return on Equity (ROE)	30.63%
Return on Assets (ROA)	7.02%
Return on Invested Capital (ROIC)	9.85%
Return on Capital Employed (ROCE)	18.68%
Revenue Per Employee	327,762
Profits Per Employee	52,308
Employee Count	10,300
Asset Turnover	0.65
Inventory Turnover	3.06

Taxes

In the past 12 months, DexCom has paid 177.28 million in taxes.

Income Tax	177.28M
Effective Tax Rate	24.85%

Stock Price Statistics

The stock price has decreased by -19.49% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-19.49%
50-Day Moving Average	77.66
200-Day Moving Average	83.37
Relative Strength Index (RSI)	39.55
Average Volume (20 Days)	5,373

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.06

Income Statement

In the last 12 months, DexCom had revenue of GBP 3.36 billion and earned 536.16 million in profits. Earnings per share was 1.34.

Revenue	3.36B
Gross Profit	1.98B
Operating Income	578.56M
Pretax Income	713.44M
Net Income	536.16M
EBITDA	760.38M
EBIT	578.56M
Earnings Per Share (EPS)	1.34

Balance Sheet

The company has 2.47 billion in cash and 1.92 billion in debt, giving a net cash position of 555.35 million.

Cash & Cash Equivalents	2.47B
Total Debt	1.92B
Net Cash	555.35M
Net Cash Per Share	n/a
Equity (Book Value)	2.03B
Book Value Per Share	5.20
Working Capital	1.40B

Cash Flow

In the last 12 months, operating cash flow was 1.08 billion and capital expenditures -287.31 million, giving a free cash flow of 789.99 million.

Operating Cash Flow	1.08B
Capital Expenditures	-287.31M
Free Cash Flow	789.99M
FCF Per Share	n/a

Margins

Gross margin is 59.01%, with operating and profit margins of 17.22% and 15.96%.

Gross Margin	59.01%
Operating Margin	17.22%
Pretax Margin	21.24%
Profit Margin	15.96%
EBITDA Margin	22.63%
EBIT Margin	17.22%
FCF Margin	23.51%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.89%
Shareholder Yield	1.89%
Earnings Yield	2.78%
FCF Yield	4.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 5.5 and a Piotroski F-Score of 6.

Altman Z-Score	5.5
Piotroski F-Score	6